Navigation Links
Miriam Hospital study shows keys to successful long-term weight loss maintenance
Date:1/6/2014

(PROVIDENCE, R.I.) -- Researchers from The Miriam Hospital have published one of the first studies of its kind to follow weight loss maintenance for individuals over a 10-year period. The results show that long-term weight loss maintenance is possible if individuals adhere to key health behaviors. The study is published in the January 2014 issue of the American Journal of Preventive Medicine.

J. Graham Thomas, Ph.D., is the lead author on a 10-year observational study of self-reported weight loss and behavior change in nearly 3,000 participants. The participants had lost at least 30 pounds and had kept if off for at least one year when they were enrolled in the National Weight Control Registry (NWCR).

The participants were then followed for 10 years. Thomas explains that the goal of the study was to determine how well they kept the weight off and to identify predictors of successful weight loss maintenance.

Thomas says, "On average, participants maintained the majority of their weight loss over this extended follow-up period, and better success was related to continued performance of physical activity, self-weighing, low-fat diets, and avoiding overeating."

Other findings from the study show that more than 87 percent of the participants were estimated to be still maintaining at least a 10 percent weight loss at years five and 10. The researchers found that a larger initial weight loss and longer duration of maintenance were associated with better long-term outcomes. Conversely, they found that decreases in physical activity, dietary restraint and self-weighing along with increases in fat intake were associated with greater weight regain.

Thomas concludes, "This is one of the only studies to follow weight loss maintenance over such a long term. What the results tell us is that long-term weight loss maintenance is possible, but it requires persistent adherence to a few key health behaviors."


'/>"/>

Contact: Nancy Jean
njean@lifespan.org
Lifespan
Source:Eurekalert

Page: 1

Related biology news :

1. Genetic signature identified for RSV, the leading cause of infant hospitalizations worldwide
2. Florida Hospital collaborates with VTT of Finland
3. Material in dissolvable sutures could treat brain infections, reducing hospital stays
4. RI Hospital: Absence of specific enzyme in cartilage can lead to benign tumors in mice
5. Study finds taking probiotics has benefits for patients in hospitals
6. Energy efficiency could increase infection risks in hospital wards
7. BGI Health forms partnership with ACIBADEM hospital on genetic disease testing
8. St. Jude Childrens Research Hospital announces issuance of US patent for cancer therapy
9. Drug-resistant MRSA bacteria -- here to stay in both hospital and community
10. Planning for bacteria in cancer patients may help hospitals fight infections
11. Childrens Hospital of Philadelphia receives federal grant to improve health care decision-making
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 19, 2017 According to a new report published by ... - 2022," the global biometric sensor market is expected to garner $1.5 billion ... 2015, Asia-Pacific dominated the global market and contributed over ... Continue Reading ... ...
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic ... to mergers and acquisitions (M&A), and Kalorama Information expects ... such acquisitions have been shifting. Generally, uncertainty in reimbursement ... and the U.S. has changed the acquisitions landscape. Instead ... resulted in companies buying partners outside of their home ...
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... Feb. 16, 2017  ArmaGen, Inc., a privately ... to treat severe neurological disorders, today reported preliminary ... AGT-181, the company,s investigational therapy for the treatment ... mucopolysaccharidosis type I, or MPS I). The initial ... study, presented today at the 13 th ...
(Date:2/16/2017)...   Biostage, Inc. (Nasdaq: BSTG ... bioengineered organ implants to treat cancers and other life-threatening ... the closing on February 15, 2017 of its previously ... and warrants to purchase 20,000,000 shares of common stock, ... was priced at $0.40 per share of common stock, ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
(Date:2/16/2017)... 16, 2017  Windtree Therapeutics, Inc. (Nasdaq: ... developing aerosolized KL4 surfactant therapies for respiratory diseases, ... study showed that aerosolized KL4 surfactant reduced lung ... preclinical animal model. The Company believes that these ... evidence that supports the role of KL4 surfactant ...
Breaking Biology Technology: